Company
Chronicle Bio
Bringing together data, biology, and intelligence to reveal insights hidden within complex chronic disease.
Also known as CHRONICLE BIO, INC., ChronicleBio
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- CHRONICLE BIO, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Eliminate the $5T burden borne by millions of patients suffering from complex chronic disease by building the largest living data ecosystem that powers AI-driven therapies and commercial breakthroughs at scale.
Funding snapshot
- Total raised
- $5.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10.3M2025-09-30
Funding rounds
- Round, 2025
- $10.3M2025-09-30, SEC form D sold, 38 investors
- Round, 2025
- $5.4M2025-09-30, SEC form D sold, 29 investors
Loading relationship preview